QLS1410 in Participants With Uncontrolled Hypertension

Summary

The goal of this clinical trial is to measure the efficacy and safety of QLS1410 in participants with uncontrolled hypertension (uHTN) or treatment-resistant hypertension (rHTN). The main objective is to compare the difference in systolic blood pressure（SBP) change from baseline at Week 12 of treatment between participants receiving QLS1410 tablets and participants receiving placebo tablets.

Timeline

Start

2026-04

Primary completion

2026-12

Completion

2027-03

Drugs

Indications